Manning Sarah, Hackney Eleanor, Dunneram Yashvee, Hull Mark A, Mitra Suparna, Stewart Christopher J, Louca Panayiotis, Meader Nick, Sharp Linda, Rees Colin
South Tyneside and Sunderland NHS Foundation Trust, South Tyneside District Hospital, South Shields, UK.
Newcastle University, Population Health Sciences Institute, Newcastle University Centre for Cancer, Newcastle Upon Tyne, UK.
Aliment Pharmacol Ther. 2025 Sep;62(6):568-584. doi: 10.1111/apt.70252. Epub 2025 Aug 12.
The human gut microbiome is of academic and clinical interest. Associations between certain organisms and colorectal neoplasia have been reported, but findings have limited reproducibility in different populations.
We performed a systematic review of whole metagenome shotgun sequencing studies using faecal samples from patients with colorectal neoplasia and control populations. Searches were performed on 30th June 2023. We identified 26 studies, reporting on 22 study populations (13 from Asia, five from Europe and four from North America). Study size ranged from 14 to 971 individuals (mean 170).
Some reproducible data were identified, such as the significant enrichment of Fusobacterium nucleatum and Parvimonas micra in colorectal cancer patients compared to controls (in 10 and nine studies, respectively). However, 21 out of 26 studies scored poorly on quality appraisal, specifically surrounding selection of cases and controls. Definitions of controls varied; some studies used individuals with normal endoscopic investigations, some used 'healthy' individuals where no colonoscopy was performed, and one used those with non-neoplastic findings (haemorrhoids). There was even less reproducibility of data in studies where individuals with colorectal polyps were compared to controls, possibly because of heterogeneity in these patient groupings as a variety of definitions for 'polyp cases' were used.
Heterogeneity and potential for bias indicates that findings should be interpreted with caution. Standardised protocols to ensure robust methodology and allow pooling of large-scale data are required before these findings can be used in clinical practice (PROSPERO: CRD42023431977).
人类肠道微生物群具有学术和临床研究价值。已有报道某些微生物与结直肠肿瘤之间存在关联,但在不同人群中的研究结果可重复性有限。
我们对使用结直肠肿瘤患者和对照人群粪便样本进行的全宏基因组鸟枪法测序研究进行了系统综述。检索于2023年6月30日进行。我们识别出26项研究,涉及22个研究人群(13个来自亚洲,5个来自欧洲,4个来自北美洲)。研究规模从14人至971人不等(平均170人)。
识别出了一些可重复的数据,例如与对照组相比,具核梭杆菌和微小消化链球菌在结直肠癌患者中显著富集(分别在10项和9项研究中)。然而,26项研究中有21项在质量评估方面得分较低,特别是在病例和对照的选择方面。对照的定义各不相同;一些研究使用内镜检查正常的个体,一些使用未进行结肠镜检查的“健康”个体,还有一项使用有非肿瘤性病变(痔疮)的个体。在将结直肠息肉患者与对照组进行比较的研究中,数据的可重复性更低,这可能是因为这些患者分组存在异质性,因为对“息肉病例”使用了多种定义。
异质性和偏倚可能性表明,对研究结果的解释应谨慎。在这些研究结果可用于临床实践之前,需要标准化方案以确保稳健的方法并允许汇总大规模数据(国际前瞻性系统评价注册库:CRD42023431977)。